1. A multicenter, phase II study of maintenance azacitidine in older patients with acute myeloid leukemia in complete remission after induction chemotherapy. Issue 9 (14th August 2015) Authors: Griffin, Patrick T.; Komrokji, Rami S.; De Castro, Carlos M.; Rizzieri, David A.; Melchert, Magda; List, Alan F.; Lancet, Jeffrey E. Journal: American journal of hematology Issue: Volume 90:Issue 9(2015:Sep.) Page Start: 796 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase 2 trial of the oral smoothened inhibitor glasdegib in refractory myelodysplastic syndromes (MDS). (June 2019) Authors: Sallman, David A.; Komrokji, Rami S.; Sweet, Kendra L.; Mo, Qianxing; McGraw, Kathy L.; Duong, Vu H.; Zhang, Ling; Nardelli, Lisa Ann; Padron, Eric; List, Alan F.; Lancet, Jeffrey E. Journal: Leukemia research Issue: Volume 81(2019) Page Start: 56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A sequential two-stage dose escalation study of eltrombopag in patients with myelodysplastic syndrome and thrombocytopenia after hypomethylating agent failure. Issue 8 (2nd July 2020) Authors: Duong, Vu H.; Al Ali, Najla; Zhang, Ling; Padron, Eric; Sallman, David; Lancet, Jeffrey E.; List, Alan F.; Komrokji, Rami S. Journal: Leukemia & lymphoma Issue: Volume 61:Issue 8(2020) Page Start: 1901 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Association of EZH2 protein expression by immunohistochemistry in myelodysplasia related neoplasms with mutation status, cytogenetics and clinical outcomes. (23rd January 2018) Authors: McGraw, Kathy L.; Nguyen, Johnny; Al Ali, Najla H.; Komrokji, Rami S.; Sallman, David; Zhang, Xiaohui; Song, Jinming; Padron, Eric; Lancet, Jeffrey E.; Moscinski, Lynn C.; List, Alan F.; Zhang, Ling Journal: British journal of haematology Issue: Volume 184:Number 3(2019) Page Start: 450 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Autoimmune diseases and myelodysplastic syndromes. Issue 5 (4th April 2016) Authors: Komrokji, Rami S.; Kulasekararaj, Austin; Al Ali, Najla H.; Kordasti, Shahram; Bart‐Smith, Emily; Craig, Benjamin M.; Padron, Eric; Zhang, Ling; Lancet, Jeffrey E.; Pinilla‐Ibarz, Javier; List, Alan F.; Mufti, Ghulam J.; Epling‐Burnette, Pearlie K. Journal: American journal of hematology Issue: Volume 91:Issue 5(2016:May) Page Start: E280 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Bone marrow cellularity at day 14 is the most important predictive factor for response in patients with AML who require double‐induction chemotherapy: Analysis from a large, single institution experience. Issue 3 (3rd February 2017) Authors: Griffin, Patrick T.; Komrokji, Rami S.; Sweet, Kendra; Al Ali, Najla H.; Padron, Eric; Kubal, Timothy E.; List, Alan F.; Lancet, Jeffrey E. Journal: American journal of hematology Issue: Volume 92:Issue 3(2017:Mar.) Page Start: 232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Clinical characteristics and outcomes of EZH2-mutant myelodysplastic syndrome: A large single institution analysis of 1774 patients. (January 2023) Authors: Ball, Somedeb; Aguirre, Luis E.; Jain, Akriti G.; Ali, Najla Al; Tinsley, Sara M.; Chan, Onyee; Kuykendall, Andrew T.; Sweet, Kendra; Lancet, Jeffrey E.; Sallman, David A.; Hussaini, Mohammad Omar; Padron, Eric; Komrokji, Rami S. Journal: Leukemia research Issue: Volume 124(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Clinical prognostic factors and outcomes of essential thrombocythemia when transformed to myelodysplastic syndromes and acute myeloid leukemia. (March 2016) Authors: Suleiman, Yaman; Dalia, Samir; Liu, Jane Jijun; Bowers, Jeremy W.; Padron, Eric; Lancet, Jeffrey E.; Fulp, William; Moscinski, Lynn C.; Komrokji, Rami S.; Zuckerman, Kenneth S.; Zhang, Ling Journal: Leukemia research Issue: Volume 42(2016:Mar.) Page Start: 52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Comparison of induction strategies and responses for acute myeloid leukemia patients after resistance to hypomethylating agents for antecedent myeloid malignancy. (June 2020) Authors: Talati, Chetasi; Goldberg, Aaron D.; Przespolewski, Amanda; Chan, Onyee; Ali, Najla Al; Kim, Jongphil; Famulare, Chris; Sallman, David; Padron, Eric; Kuykendall, Andrew; Lancet, Jeffrey E.; Wang, Eunice; Tallman, Martin S.; Komrokji, Rami; Sweet, Kendra Journal: Leukemia research Issue: Volume 93(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Comparison of mutational profiles and clinical outcomes in patients with acute myeloid leukemia with mutated RUNX1 versus acute myeloid leukemia with myelodysplasia-related changes with mutated RUNX1. Issue 6 (11th May 2020) Authors: Nguyen, Lynh; Zhang, Xiaohui; Roberts, Evans; Yun, Seongseok; McGraw, Kathy; Abraham, Ivo; Song, Jinming; Braswell, Diana; Qin, Dahui; Sallman, David A.; Lancet, Jeffrey E.; List, Alan F.; Moscinski, Lynn C.; Padron, Eric; Zhang, Ling Journal: Leukemia & lymphoma Issue: Volume 61:Issue 6(2020) Page Start: 1395 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗